Leader: Nicola Hofmann (Germany)

Vice Leader: Xavier Lafarge (France)

​

Aims:

1) To discuss general regulatory issues and specific exemptions for perinatal derivatives (PnD);

2) To set commonly accepted GMP and regulatory standards;

3) To provide an understanding on patient perspectives concerning the collection and use PnD;

4) To discuss with stakeholders, including regulatory agencies, ethical, legal and insurance issues for donation, processing and use of Pn tissues;

5) To guide clinicians for optimal clinical trial design and the successful implementation of efficient and safe clinical trials.

​

Members:

Dorela Kroni (Albania)

Marcin Jurga (Belgium)

Elma Mrehic' (Bosnia Herzegovina)
Mariastefania Antica (Croatia)
Susanna Miettinen (Finland; STSM Committee Member)

Anna Chioti (Luxembourg)

Andreas Kremer (Luxembourg)

Hanne Scholtz (Norway)

Cecilia Götherström (Sweden)

Volodymyr Shablii (Ukraine)